SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-24-091998
Filing Date
2024-04-10
Accepted
2024-04-10 16:50:56
Documents
1
Group Members
JOSEPH EDELMANPERCEPTIVE LIFE SCIENCES MASTER FUND, LTD.PERCEPTIVE XONTOGENY VENTURE FUND, L.P.PX VENTURE (A), LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d770327dsc13da.htm SC 13D/A 89388
  Complete submission text file 0001193125-24-091998.txt   91111
Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 646-205-5300
PERCEPTIVE ADVISORS LLC (Filed by) CIK: 0001224962 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Subject) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92247 | Film No.: 24836409
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)